OPINION AND ORDER
1. INTRODUCTION
This Court’s prior holdings establish that: (1) Vivendi Universal, S.A. (“Vivendi”) is precluded from contesting the elements of a Section 10(b) claim, save for reliance; (2) GAMCO Investors, Inc. (“GAMCO”) is entitled to the fraud on the market presumption, which shifts the burden to Vivendi to disprove reliance; and (3) Vivendi is precluded from raising the truth on the market defense to rebut the presumption of reliance. Based on these holdings, plaintiff GAMCO moves for summary judgment on its Section 10(b) claim against Vivendi on the grounds that discovery is complete, and no facts exist which disprove reliance.
II. FACTS
On July 15, 2009, GAMCO filed an Amended Complaint alleging that Vivendi had violated Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) with respect to GAMCO’s transaction in Vivendi’s American Depositary Receipts (“ADRs”), which traded on the New York Stock Exchange during the period October 30, 2000 through August 14, 2002 (the “Class Period”).
On January 29, 2012, the jury in the class action In re Vivendi Universal S.A. Securities Litigation
Vivendi sets forth the following additional facts relevant to its opposition. GAM-CO, a wholly owned subsidiary of Gabelli Asset Management, Inc. (“GBL”), is an investment advisor with a broad spectrum of clients.
GBL held daily morning meetings during which Gabelli & Company securities analysts presented research on the companies they covered to portfolio managers,
Vivendi presents evidence that GBL’s portfolio managers corresponded and/or met with Vivendi management, including Vivendi’s CEO Jean-Marie Messier, on multiple occasions during the relevant period.
Q. Have you ever met or corresponded with Jean-Marie Messier?
A. Yes.
Q. Did you meet with Jean Marie Messier during the relevant time period?
A. Maybe.
Q. Did you correspond with Messier during the relevant time period?
A. Maybe.
Q. Do you have any recollection of a specific conversation you had with Jean-Marie Messier during the relevant time period?
A. No.19
Furthermore, GAMCO employees occasionally participated in public Vivendi conference calls.
Vivendi presents evidence that the only valuation metric used by GAMCO in connection with trading Vivendi was “private market value” (“PMV”).
III. SUMMARY JUDGMENT STANDARD
“Summary judgment is designed to pierce the pleadings to flush out those cases that are predestined to result in a directed verdict.”
In a summary judgment setting, “[t]he burden is on the moving party to demonstrate that no genuine issue respecting any material fact exists.”
IV. APPLICABLE LAW
A. Section 10(b) of the Securities Exchange Act and Rule 10b-5
Section 10(b) of the Exchange Act makes it illegal to “use or employ, in connection with the purchase or sale of any security ... any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe....”
1. Reliance
The reliance and loss causation elements of a securities fraud claim are analogous to but-for and proximate causation, respectively.
Additionally, the plaintiff must show that his reliance was reasonable.
(1) The sophistication and expertise of the plaintiff in financial and securities matters; (2) the existence of longstanding business or personal relationships; (3) access to the relevant information; (4) the existence of a fiduciary relationship; (5) concealment of the fraud; (6) the opportunity to detect the fraud; (7) whether the plaintiff initiated the stock transaction or sought to expedite the transaction; and (8) the generality or specificity of the misrepresentations.49
a. The Fraud on the Market Presumption
In Basic v. Levinson, the Supreme Court held that, under certain circumstances, a plaintiff is entitled to a rebuttable presumption (the “fraud on the market presumption”) that she relied on the integrity of the market price of a security.
In short, “[t]he ... fraud-on-the-market theory involves two rebuttable presumptions that permit a finding of ... reliance ...: ‘that (1) misrepresentations by an issuer affect the price of securities traded in the open market, and (2) investors rely on the market price of securities as an accurate measure of their intrinsic value.’ ”
One way to “sever the link” is to demonstrate that the alleged misrepresentation did not impact the market price. For example, a defendant could show that the misstatement was known to be false by market makers,
V. DISCUSSION
In opposing summary judgment, Vivendi argues that a reasonable jury could find that it has rebutted the fraud on the market presumption by finding that: (1) GAM-GO’s reliance was unreasonable because it either had, or should have had, reason to doubt Vivendi’s public statements;
A. Vivendi Has Raised a Material Question of Fact With Respect to the Reasonableness of GAMCO’s Reliance
In this Circuit, “a plaintiffs reliance on the defendant’s misrepresentation must have been reasonable in order for the claim to proceed.”
When the plaintiff seeks to prove reliance through fraud on the market, this reasonableness inquiry applies only to the extent that corrective information was known either to the plaintiff or to the market.
A condition precedent to the fraud on the market presumption is that the misrepresentation was material, ie., that it would be expected to alter the price of the security. Defendants can therefore rebut this presumption by showing that the price was not affected by the misstatement or omission.
Vivendi is precluded from contesting the materiality of its misstatements by using the truth on the market defense to rebut the fraud on the market presumption.
In Jones, the district court held that, under Third Circuit precedent, the plaintiff short-sellers were not entitled to the fraud on the market presumption, but could directly prove reliance by establishing the elements of fraud on the market.
In Cromer, a putative class brought an action against, among others, Deloitte & Touche Bermuda (“Deloitte”), the auditor of an offshore investment fund, alleging that Deloitte had issued clean audit reports for the fund despite having information that the fund’s net asset value statements (“NAV’s”) were fraudulent.
Finally, ML-Lee, a District of Delaware case, holds that sophisticated plaintiffs in private-market transactions are held to a higher standard of due diligence and that, because the putative lead plaintiffs might be subject to unique defenses which would destroy the typicality requirement for class certification, defendants were entitled to discovery of the plaintiffs’ investment history.
Moreover, “almost all of the cases in which courts have found that a sophisticated investor had an enhanced duty to investigate involved face-to-face transactions, not purchases on an open securities market.”
This is just another way to state the common law rule that contributory negligence is not a defense to an intentional or reckless tort. The best solution is for people not to harm others intentionally, not for potential victims to take elaborate precautions against such depradations. If the victims’ failure to take precautions were a defense, they would incur costs to take more precautions (and these costs are a form of loss victims would feel in every case, even if the tort does not occur), while would-be tortfeasors would commit additional torts because they would not fear the need to pay up in cases where the victims do not protect themselves. Common law courts have balked at such an outcome in ordinary tort cases, and securities law has followed the same path.88
In sum, sophisticated investors are not held to a higher standard of due diligence than ordinary investors when they purchase securities on the open market, as GAMCO did.
To the extent that Vivendi’s argument is that GAMCO should have unearthed information that would have led it to discount Vivendi’s misrepresentations, such arguments fails because contributory negligence is not a defense to securities fraud. The argument that GAMCO could have unearthed such information, though, presents a fact issue for trial. GAMCO insists that the “fact that GAMCO did not trade while in possession of non-public information” is “undisputed.”
If GAMCO learned corrective nonpublic information from these meetings or correspondences, it would serve to rebut
In sum, Vivendi has presented enough evidence that GAMCO “ ‘had access to and knowledge of ” corrective information to withstand summary judgment.
B. Vivendi Has Raised Material Question of Fact as to Whether GAMCO Purchased Vivendi Securities Regardless of Their Market Price
Vivendi’s two remaining arguments opposing summary judgment are closely related. Vivendi argues that there is a material issue of fact with respect to reliance because: first, the brand of value-based investing that GAMCO applied to Vivendi did not take into account the price of Vivendi’s shares;
It is somewhat ironic that GAMCO, a value-based investor, is relying on the fraud on the market presumption, which is grounded on the reliability of the market price that value-based investors spend their lives second-guessing. In support of its argument that GAMCO’s investment in Vivendi was not induced by the market price of Vivendi’s securities, Vivendi presents the statements of a number of GBL employees stating that PMV does not take market price into account.
In fact, “GAMCO made its largest one-day purchase of Vivendi shares on July 2, 2002, a day on which Dr. Nye testified that Vivendi’s true liquidity condition was revealed by credit rating downgrades to junk status.”
In response, GAMCO argues that Vivendi’s “subjective belief that a security’s market price is undervalued is [in]sufficient to destroy [GAMCOJ’s reliance on the integrity of the market[,]” because every investor thinks the securities they transact in are over- or under-valued.
According to GAMCO, the relevant inquiry is whether it would have entered the same transactions at the same prices absent Vivendi’s fraud; whether GAMCO would have entered into different transactions at different prices is of no moment.
GAMCO further argues that it did not rely solely on PMV when it decided to invest in Vivendi and that, in any case, PMV is not insensitive to accounting fraud. In support of the first point, GAMCO quotes the June 25, 2007 deposition of Mario Gabelli, in which Gabelli states that GAMCO “[would determine if Vivendi securities were undervalued] ... using a variety of stock specific dynamics ... [including] [e]arnings per share, PMV, EBITDA [ (earnings before income, tax, depreciation, and amortization) ] ... a whole mosiac.”
As an initial point, it bears repeating that class certification and the class jury trial have passed, and that the current posture of the instant case involves Vivendi’s challenge to GAMCO’s reliance. The February 17 Opinion notes that questions of individual reliance will not defeat class certification when a trial on common issues is possible, but rather will “call for separate inquiries into the individual circumstances of particular class members.”
Equally inapposite are GAMCO’s citations to a line of cases that stand for the proposition that short-sellers are entitled to the fraud on the market presumption, despite the fact that short-sellers buy securities that they think are undervalued.
At its core, GAMCO’s argument is that Vivendi has not raised a material issue of fact because it has not shown that: (1) GAMCO would have entered the same transactions, at the same prices, absent the material misstatements; or that (2) GAMCO’s post-disclosure transactions in Vivendi securities were not made in reliance on the integrity of the market price. As to the first point, it is true that courts at times use the formulation that the fraud on the market presumption can be rebutted if “defendant can show that plaintiff would have purchased the stock at the same price even if [s]he had [ ] known the non-disclosed information....”
All of the cases cited by GAMCO in support of the second point
GAMCO acknowledges that post-disclosure purchases can defeat the typicality requirement for class certification when “plaintiffs made a ‘disproportionately large percentage’ of their purchases post-disclosure ....”
In sum, Vivendi has raised a material question of fact as to whether GAMCO actually relied on the market price of Vivendi’s securities when it invested in Vivendi. GAMCO’s post-disclosure purchases are probative of that reliance, or the lack thereof. Therefore, GAMCO’s motion for summary judgment is denied.
VI. CONCLUSION
For the foregoing reasons, GAMCO’s motion for summary judgment is denied. The Clerk of Court is directed to close this motion (Docket No. 105).
SO ORDERED.
Notes
. Familiarity with the extensive factual and legal background of this litigation is presumed. See In re Vivendi Universal, S.A. Sec. Litig. (“Feb. 17 Op.”),
. See Memorandum of Law in Support of Plaintiff’s Motion for Summary Judgment Against Defendant Vivendi, S.A. at 1-2.
. The following facts are drawn from GAM-CO’s Statement Under Rule 56.1 in Support of Plaintiff’s Motion for Summary Judgment Against Defendant Vivendi, S.A. ("56.1 Statement”) and Defendant Vivendi, S.A.'s Response to Plaintiff GAMCO Investors, Inc.’s Statement Under Rule 56.1 in Support of Its Motion for Summary Judgment Against Defendant Vivendi, S.A. and Statement of Additional Facts Pursuant to Local Rule 56.1 ("56.1 Counter-statement”). The material facts are not in dispute for the purposes of this motion. Both the 56.1 Statement and the 56.1 Counter-statement are supported by citations to evidence admissible at trial. These citations are omitted.
. See 56.1 Statement ¶ 1.
. No. 02 Civ. 5771 (S.D.N.Y).
. 56.1 Counter-statement at 2. See 56.1 Statement ¶ 3.
. See Feb. 17. Op.,
. Id. at 584-85.
. See 56.1 Statement ¶ 5 (citing In re Vivendi Universal, S.A. Securities Litigation, No. 02 Civ. 5571,
. See 56.1 Counter-statement ¶ 1.
. See id. ¶ 3.
. See id. ¶ 4.
. See id. ¶ 5.
. See id. ¶ 6.
. See id. ¶ 7.
. See id. ¶ 10 (citing 12/26/06 Deposition of Caesar Bryan (portfolio manager at GBL) ("Bryan Dep.”), Ex. 8 to Declaration of Daniel Slifkin in Support of Defendant Vivendi, S.A.'s Memorandum of Law in Opposition to Plaintiff's Motion for Summary Judgment Against Defendant Vivendi, S.A. ("Slifkin Decl.”), at 88:3-10; 6/8/7 Deposition of Mario Gabelli (GBL Chairman and CEO) ("6/8/07 Gabelli Dep.”), Ex. 2 to Slifkin Decl., at 106:5-13).
. Bryan Dep. at 88-8:10.
. Id. at 88:14-16.
. 6/8/7 Gabelli Dep. at 106:5-17.
. See 56.1 Counter-statement ¶ 11.
. See id. ¶ 8.
. Id. ¶ 9.
. See id. ¶ 12.
. See id. ¶ 13.
. See id. ¶ 14.
. Compare id. If 15 with Reply Memorandum of Law in Further Support of Plaintiff's Motion for Summary Judgment Against Defendant Vivendi, S.A. ("Reply Mem.") at 10.
. See 56.1 Counter-statement ¶ 16.
. See id. ¶ 17.
. Lightfoot v. Union Carbide Corp.,
. Fed.R.Civ.P. 56(c).
. Sanchez v. Connecticut Natural Gas Co.,
. Carter v. Incorporated Vill. of Ocean Beach,
. Miner v. Clinton County, N.Y.,
. Mavrommatis v. Carey Limousine Westchester, Inc.,
. Cordiano v. Metacon Gun Club, Inc.,
. See id.
. Brown v. Eli Lilly & Co.,
. Id. (quoting Federal Deposit Ins. Corp. v. Great Am. Ins. Co.,
. Brod v. Omya, Inc.,
. Kaytor v. Electric Boat Corp.,
. Brod,
. 15 U.S.C. § 78j(b).
. 17 C.F.R. § 240.10b-5.
. Ashland Inc. v. Morgan Stanley & Co., Inc.,
. See ATSI Commc'ns, Inc. v. Shaar Fund, Ltd.,
. Erica P. John Fund, Inc.,
. See Starr ex rel. Estate of Sampson v. Georgeson Shareholder, Inc.,
. Brown v. E.F. Hutton Group, Inc.,
. Id. (citations omitted).
.
. Id. at 227,
. Id. at 247,
. In re Salomon Analyst Metromedia Litig.,
. See Erica P. John Fund, Inc.,
. Teamsters Local 445 Freight Div. Pension Fund v. Bombardier Inc.,
. Basic,
. See id. at 248,
. See id.
. Teamsters Local 445 Freight Div. Pension Fund,
. See Basic,
. See Memorandum of Law in Opposition to Plaintiff's Motion for Summary Judgment Against Defendant Vivendi, S.A. ("Opp. Mem.”) at 15 ("A jury could find that GAMCO’s reliance was unreasonable either because GAMCO learned information during meetings or conference calls or from its own research that undermined Vivendi’s public statements, or because given what GAMCO knew from its research and experience, it should have asked questions that would have led to the truth.”).
. See id. at 10 ("[I]f Vivendi presents evidence that creates a genuine issue of material fact regarding whether GAMCO would have nonetheless purchased Vivendi stock even if it had known of the alleged fraud, summary judgment must be denied.”).
. See id. at 14 ("Given GAMCO's investment philosophy, a reasonable jury could find that GAMCO did not rely on the integrity of the market in making its purchase decisions, which would rebut the presumption of reliance and allow the jury to find in favor of Vivendi.”).
. Ashland Inc. v. Morgan Stanley & Co., Inc.,
. See, e.g., Hunt v. Alliance North Am. Gov’t Income Trust, Inc.,
. Cf. Maverick Fund, L.D.C. v. Comverse Tech., Inc.,
. See Basic,
. See In re Salomon Analyst Metromedia Litig.,
. See Basic,
. See, e.g., Ganino v. Citizens Utilities Co.,
. See Opp. Mem. at 1 (acknowledging that Vivendi is collaterally estopped from contesting materiality or introducing the truth on the market defense).
.
.
.
. See Jones,
. Jones,
. See id. at 633 ("Plaintiffs were certainly not fooled by this tactic, for they themselves explain that they perceived it as misleading when they noticed it in IDN's previous filings and press releases — indeed, that is precisely why plaintiffs allege they began to short sell IDN's stock in the first place.”).
. See Opp. Mem. at 1.
. See Cromer Fin. Ltd.,
. See id. at 130 ("In some ways this is an even stronger case for applying a presumption than those that have embraced the [fraud on the market theory] since it would not be based on the assumption that the representations from either Ernst & Young or Deloitte affected the price. Instead, the Ernst & Young calculations and NAV statements were the price per share, and Deloitte’s audits were an explicit confirmation of the process for calculating that price.”) (emphasis in original).
. See id. at 132.
. Id. at 132-33 (footnote omitted).
. See GAMCO’s 9/15/9 Amended Complaint for Violations of the Federal Securities Laws ¶ 214(c); Opp. Mem. at 5 (stating that "GAMCO purchased Vivendi stock throughout the relevant period”) (citation omitted); Reply Mem. at 6 ("In the present case, it is clear that GAMCO executed each Vivendi ADR transaction on the New York Stock Exchange and never in the face-to-face context.").
. See In re ML-Lee Acquisition Fund II, L.P. and ML-Lee Acquisition Fund (Retirement Accounts) II, L.P. Secs. Litig.,
. Id.
. Maverick Fund, L.D.C.,
.See Maverick Fund, L.D.C.,
. Teamsters Local 282 Pension Trust Fund v. Angelos,
. See GAMCO's 9/15/9 Amended Complaint for Violations of the Federal Securities Laws ¶ 214(c); Opp. Mem. at 5 (stating that "GAM-CO purchased Vivendi stock throughout the relevant period”) (citation omitted); Reply Mem. at 6 ("In the present case, it is clear that GAMCO executed each Vivendi ADR transaction on the New York Stock Exchange and never in the face-to-face context.”).
. See Opp. Mem. at 1.
. See id. at 14-15.
. Id. at 15.
. Reply Mem at 1.
. See 56.1 Counter-statement ¶ 10 (citations omitted).
. Feb. 17 Op.,
. See Opp. Mem. at 13 ("GAMCO does not rely on the integrity of the market to value shares accurately, because its entire strategy for purchasing shares depends on the assumption that the market price does not reflect a company’s true value.”).
. See id. at 13-14.
. Id. at 10. (citation omitted).
. Id. (citations omitted).
. See id. at 11-12.
. Reply Mem. at 2.
. See id. at 7.
. Id. (quoting Rosen v. Textron, Inc.,
. See id. at 8-9 (citations omitted).
. Id. at 8 (emphasis removed).
. Id. at 9-10 (quoting 6/25/07 Deposition of Mario Gabelli, Ex. E to Declaration of Vincent R. Cappucci in Support of Plaintiff’s Motion for Summary Judgment against Defendant Vivendi, S.A. (“Cappucci Decl.”), at 163:11-21) (emphasis removed).
. Id. at 10 (quoting 10/20/06 Deposition of Henry Van der Eb, portfolio manager at GAMCO, Ex. H to Cappucci Decl., at 36:21-37:3).
. Id. at 11.
. See id. at 11-12 (citing In re Moody's Corp. Sec. Litig.,
. See id. at 12-13 (citations omitted).
. Feb. 17 Op.,
. See, e.g., Reply Mem. at 3 (citing the following class-action certification cases: In re Pfizer Inc. Sec. Litig.,
. City of Livonia Employees’ Retirement Sys. v. Wyeth,
. See, e.g., Reply Mem. at 2-3 (citing Argent Classic Convertible Arbitrage Fund L.P. v. Rite Aid Corp.,
. See, e.g., Argent Classic Convertible Arbitrage Fund L.P.,
. See Reply Mem. at 2-3.
. Lawrence v. Phillip Morris Cos., Inc., No. 94 Civ. 1494,
. See Opp. Mem. at 12 (quoting 8/31/06 Deposition of Andrew Rittenberry, Ex. 1 to Slifkin Decl., at 133:11-134:16).
. See Reply Mem. at 10-12.
. In re DVI Inc. Sec. Litig.,
. See, e.g., Feder v. Electronic Data Sys. Corp.,
. Reply Mem. at 12-13 (quoting City of Livonia,
. In re DVI Inc. Sec. Litig.,
. Reply Mem. at 12.
